INTRODUCTION
============

Induced sputum analysis is one of representative tests to define airway inflammatory phenotype in asthma \[[@B1]\]. It has been standardized about a decade ago, and has been widely used in research and practice due to its reproducibility and less invasiveness \[[@B2], [@B3]\]. Induced sputum eosinophil is still one of the most useful biomarkers for asthma \[[@B1]\]; as it has clinical utility in phenotyping asthma or predicting the treatment response \[[@B1], [@B4], [@B5]\]. However, currently available reference levels (defined as more than 3% of eosinophil count in total cell count) have been derived from Western population studies \[[@B6], [@B7], [@B8], [@B9], [@B10]\], but not have been examined in Korean adults yet. Considering the potential heterogeneity in fractional exhaled nitric oxide (FeNO) levels among ethnic groups \[[@B11]\], induced sputum profiles also need to be examined specifically for Korean populations. In this study, we aimed to determine reference ranges for induced sputum eosinophil in healthy Korean adults.

MATERIALS AND METHODS
=====================

Subjects
--------

Healthy adult volunteers were recruited by public posting from visitors to Seoul National University Hospital, Seoul, Korea. The recruitment was carried out from November 2010 to September 2011. Inclusion criteria were (1) age over 19-year-old, (2) no history of respiratory tract disease in previous 3 months, (3) no evidence of systemic infection in previous 3 months, and (4) absence of asthma related symptom and airway hyperresponsiveness (defined as methacholine provocative concentration causing 20% fall in forced expiratory volume during 1 second \[PC~20~\]≤16 mg/mL). Finally, 208 healthy volunteers were recruited, and all of them underwent induced sputum tests. All the participants were given written informed consents. The study protocol was approved by the Institutional Review Board of Seoul National University Hospital (IRB no. 1012-061-344).

Sputum induction and processing
-------------------------------

First, we check baseline forced expiratory volume during 1 second (FEV~1~). They were pretreated with salbutamol 2 puff as a bronchodilator. Sputum was induced with hypertonic saline 4.5% via ultrasonic nebulizer, and was collected into a petri dish which was placed on the ice. FEV~1~ was checked every 5 minutes during 20 minutes. The sample was kept at 4℃, and sputum processing was performed within 4 hours of induction, with minor modifications of the European Respiratory Society standard protocol \[[@B12]\]. We removed saliva with the pipet and determined the volume of sputum. The equal volume of 0.01M dithioerythritol was added, and we gently mixed them. These were filtered with 100-µm cell strainer or mesh on 15-mL tube and centrifuged with 1,000 or 2,000 rpm for 10 minutes at 4℃. We aspirated supernatant 1 to 1.5 mL into a cryotube and freezed them at -20℃ or -80℃. The cell pellet was resuspended with 1-mL phosphate buffered saline (PBS). The volume of 10-µL suspension was added with 90-µL trypan blue. We determined cell counts and then dilute cell suspension with PBS to obtain 1×10^5^ cells/mL. The cytospin was done at 500 rpm for 5 minutes at 4℃, and the Diff Quick stain was done. Finally we counted cells as %, except the epithelial cells.

Skin prick tests
----------------

The inhalant allergen skin prick test was performed to determine atopic status. Major inhalant allergens were evaluation, including *Dermatophagoides pteronyssinus*, *Dermatophagoides farinae*, cat, dog, tree mix, grass mix, ragweed, mugwort, cockroach, *Alternaria* spp., and *Aspergillus fumigatus*. Normal saline and histamine were used to negative and positive control. Atopy was defined if there are positive results (median wheal size ≥3 mm or larger than size of histamine, and median flare size ≥10 mm) to one or more allergen.

Fractional exhaled nitric oxide
-------------------------------

FeNO was measured by using NIOX MINO (Aerocrine, Solna, Sweden), according to the guidelines \[[@B13]\]. Briefly, they were asked to avoid medication or food intake which could interfere with the results. They were also instructed to avoid smoking or exercise within one hour before on the day of testing \[[@B14]\]. Then, they inhaled over 2-3 seconds to total lung capacity through NIOX filter, and exhaled as an upper airway pressure of 5-20 cm H~2~O. FeNO was measured during its plateau status at least for 3 seconds. As the lower detection limit was 5 parts per billion (ppb), the values \<5 ppb were considered as 2.5 ppb. In this analysis, average levels of at least two acceptable measurements were utilized.

Statistical methods
-------------------

Statistical analyses were performed with SPSS ver. 10.0 (SPSS Inc., Chicago, IL, USA). As sputum inflammatory cell counts were not normally distributed, their distributions were described as median and ranges. The associations between cell counts and clinical factors were analyzed by the Mann-Whitney tests and the Spearman correlation tests. Results were considered significant when two-sided *p* values \<0.05.

RESULTS
=======

Baseline characteristics
------------------------

From 208 healthy volunteers who underwent induced sputum tests, 81 samples (38.9%) were eligible for analyses. The reasons for ineligibility were inadequate quality of sputum (n = 20), and failure to induce sputum (n = 107), presumably due to the lack of airway inflammation. Baseline characteristics of the study subjects were described in [Table 1](#T1){ref-type="table"}. Female were predominant (66.7%) and a mean age was 52.3 ± 13.1 years. Body mass index values were over 23.7 ± 3.4 kg/m^2^. Most of subjects (77.8%) were never-smoker and 20 subjects (31.3%) had atopy. There was no subject who had peripheral blood eosinophilia (≥500/µL). Most of subjects (72.8%) had low value of FeNO (\<25 ppb) and the maximum value of FeNO was 49 ppb. Minimum value of sputum eosinophil was 0% and maximum value was 11%.

Distribution of inflammatory cells in induced sputum of healthy subjects
------------------------------------------------------------------------

The distribution of induced sputum inflammatory cells in healthy subjects was described in [Table 2](#T2){ref-type="table"}. Macrophage and neutrophil were predominant cells in induced sputum. Macrophage had a median of 71.3% (range, 0-97.3%), and the upper 90 percentile of 89.2%. Neutrophil had a median of 24.7% (range, 0.7-100%), and the upper 90 percentile of 96.0%. Eosinophil had a median of 0% (range, 0-11%), and the upper 90 percentile of 3.5%. The distribution of induced sputum eosinophil was also presented in [Fig. 1](#F1){ref-type="fig"}.

Associations of sputum inflammatory cells with demographic and clinical parameters
----------------------------------------------------------------------------------

Associations of sputum eosinophil or neutrophil counts with demographic and clinical parameters were analyzed ([Tables 3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}). For eosinophils, subjects with atopy showed significantly higher counts than those without atopy. Distribution of induced sputum eosinophils (%) according to presence of atopy was presented in [Fig. 2](#F2){ref-type="fig"}. However, no significant correlations were found with age, gender, smoking, body mass index, allergic rhinitis, peripheral blood eosinophil%, or FeNO levels. For neutrophils, no significant associations were found with any of these factors.

DISCUSSION
==========

The present study reported, for the first time, the normal range of induced sputum eosinophils among Korean healthy adults. The range (3.5% as 90 percentile) was comparable to those from previous studies conducted in Western populations \[[@B6], [@B7]\].

Airway inflammation is an important pathogenesis underlying airway diseases such as asthma, chronic obstructive pulmonary disease, or chronic cough \[[@B15]\]. Therefore, to obtain airway sample is a mandatory step for both of research and clinical purposes. This is why, induced sputum test has gained a considerable popularity as a safe noninvasive alternative to bronchoscopy which could be at risk of exacerbations \[[@B1]\]. As, asthma is now considered as a heterogeneous entity with potentially various inflammatory phenotypes \[[@B16], [@B17]\], the necessity of the assessment is to continue.

In particular, sputum eosinophilia is a consistently important biomarker \[[@B18], [@B19]\]. Briefly, airway eosinophilia has been associated with airway obstruction, hyperresponsiveness, and corticosteroid response for asthma \[[@B20], [@B21], [@B22]\]. To determine this, the literature suggests the reference range as \<2.4% \[[@B6], [@B7]\]. However, it should be noted that the reference values were obtained from relatively small numbers of studies conducted in Western populations \[[@B6], [@B7]\]. For FeNO analyses, the potential discrepancy between different ethnic or demographic groups have been suggested (frequently higher in Asians than Caucasians) \[[@B11], [@B14]\]. That was a motivation that we attempted to determine reference ranges in Korean adults in the present study.

We found that most of Korean healthy adults have sputum eosinophil \<3.5%, which was slightly higher than previous reports \[[@B6], [@B7]\]. To our knowledge, no published literature directly compared different ethnic groups with large numbers of participants. We presume several possibilities for the discrepancy. First, the differences in clinical and demographic characteristics could have possibly influenced the results. Particularly, atopy could have been a significant factor, as also reported in the studies by Belda et al. \[[@B6]\]. Studies by Spanevello et al. \[[@B7]\], consisted of only nonatopics. The positive association between atopy and airway eosinophilia is a well-recognized finding \[[@B23]\], as both are Th2-mediated responses.

Our study population had older ages (mean, 52.3 years) and more females (66.7%) than these two reference studies (mean, 36 years and 38 years; and female, 55.2% and 47.9%, respectively) \[[@B6], [@B7]\]; however, age does not appear to correlate with sputum eosinophilia \[[@B6], [@B7]\]. Gender effects on sputum eosinophils remain elusive, but our lack of the difference might have been related to a low number of male participants; previous studies found females had 0.274% higher eosinophils than males \[[@B6]\].

Our high failure rates in sputum induction (61.1%) could also have been a bias factor. In the present study, 51.4% of participants could not expectorate sputum despite efforts. The rate of inadequate sample was 9.6%, which was comparable to total failure rates of 11.4-19% in previous studies \[[@B6], [@B7]\]. We processed the samples within 4 hours of induction, which was known to be acceptable \[[@B24]\]. We used 100-µm mesh for improving slide quality, which was larger than 40-µm nylon net filter in the international standard protocol \[[@B12]\]; however, the step of mesh filtering does not influence the sputum eosinophils \[[@B25]\].

Clinical utility of sputum neutrophilia and its consistency is still controversial, and was not fully discussed in this article. The distribution of sputum neutrophil% is wider than eosinophils, and more likely to have normal distributions \[[@B6], [@B7]\]. Airway neutrophilia has been associated with infection, irritant exposure, obesity, or sometimes with corticosteroid-resistant asthma \[[@B26]\] Among normal subjects, neutrophilia also appeared to be associated with older age \[[@B8]\].

The major limitation to our study is a sample size. We originally intended to analyze 150 or more normal subjects, but the success rate was lower than expected. Another limitation was the way of recruitment; participants were recruited from hospital visitors, which could not exclude the possibility of comorbidities other than asthma, respiratory diseases, or recent systemic infection. However, due to methodological considerations \[[@B24]\], sputum induction and processing should be performed with specialized instruments and very near to laboratories, making community-based sampling difficult.

In conclusions, the present study was the first attempt to determine the reference ranges of sputum eosinophils in Korean adults. Atopy was a clinical factor significantly associated with sputum eosinophilia.
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Baseline characteristics of healthy adults who successfully underwent induced sputum analyses (n = 81)
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Values are presented as number (%), mean ± standard deviation or median (interquartile range).

FEV~1~, forced expiratory volume in 1 second; FVC, forced vital capacity; PC~20~, provocative concentration causing a 20% fall in FEV~1~; FeNO, fractional exhaled nitric oxide; ppb, parts per billion.
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Distribution of different cell counts in induced sputum in healthy
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Values are presented as %.

###### 

Associations of sputum eosinophil/neutrophil (%) with demographic and clinical parameters
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Values are presented as median (range).

^\*^Mann-Whitney test.

###### 

Bivariate correlations of sputum eosinophil/neutrophil (%) with demographic and clinical parameters
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FeNO, fractional exhaled nitric oxide.

^\*^Spearman correlation test.
